Advertisement
Persons > United Kingdom (GB)
Please find below persons from the United Kingdom (GB) or related to British organisations.Total search results: 2831 | Ordered by Region (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Brown, Rob (Dotmatics 201501– VP Global Informatics before Biovia/Dassault Systèmes + Accelrys) | President/Director/Head Business Group/Unit/Division | Insightful Science (Group) | East of England (region) |
Browne, Kenneth William (Ken W.) (Technology Networks 2012 President + Select Biosciences Director + Founder) | Managing Director | Select Biosciences Ltd. | East of England (region) |
Buckland, Martin | n. a. | Otsuka (Group) | East of England (region) |
Burdett, Roger (Quotient Bioresearch 201201 CEO) | Chief Executive Officer (CEO) | Quotient Bioresearch (Group) | East of England (region) |
Burke, Brian (MIP Discovery 202402 Chief Commercial Officer formerly Horizon Discovery) | Chief Commercial Officer (CCO) | MIP Discovery Ltd. | East of England (region) |
Burrows, Bryony (Zetta Genomics 202304 CFO) | Chief Financial Officer (CFO) | Zetta Genomics (Group) | East of England (region) |
Burt, James (Pharmanovia 202305 CEO) | Chief Executive Officer (CEO) | Pharmanovia (Group) | East of England (region) |
Bushara, Leon (Astex –200610– CEO) | Chief Executive Officer (CEO) | Otsuka (Group) | East of England (region) |
Butchers, Carolyn (Biostrata 201411– before Alto Marketing) | Public Relations Manager / Investor Relations Manager | BioStrata Ltd. (Biostrata Marketing) | East of England (region) |
Butler, Joanne (Jo) (BioStrata 202309 Senior Account Director) | Public Relations Manager / Investor Relations Manager | BioStrata Ltd. (Biostrata Marketing) | East of England (region) |
Butt, Richard (Apollo Therapeutics 201605– CEO before Pfizer Neusentis) | Chief Executive Officer (CEO) | Apollo Therapeutics (Group) | East of England (region) |
Calvani, Enrica (Univ Cambridge 201407 Lab Manager at Ralser Group) | Laboratory Manager (university / research institute) | University of Cambridge | East of England (region) |
Cameron, Gordon (Quotient Bioresearch 2007– CFO before Acambis 2004–200706 CEO before CFO before NM Rothschild) | Chief Financial Officer (CFO) | Quotient Bioresearch (Group) | East of England (region) |
Cameron, Graham (EBI 200502) | n. a. | EMBL (European Molecular Biology Laboratory) | East of England (region) |
Cameron, Grant (Automation Partnership 201210 RAFT Development Director) | Research & Development Manager | Sartorius (Group) | East of England (region) |
Campbell, Andrew (Sphere Fluidics 201903– Director of Finance before Charles River + PerkinElmer Life Sciences) | Chief Operating Officer (COO) | Sphere Fluidics (Group) | East of England (region) |
Campbell, Ian (Akubio 200709 BusDev Director) | Business Development Manager / Strategy Manager | Abbott (Group) | East of England (region) |
Campbell, Ian (UroSens 201501 CEO before Managing Director of Molecular Vision) | Managing Director | UroSens Ltd. | East of England (region) |
Carpenter, Naomi (Expedeon 202003 VP Sales + Marketing) | Sales Manager / Marketing Manager | 2invest (Group) | East of England (region) |
Carr, Beverley (Achilles Therapeutics 201911– CBO before GSK + CAT + MedImmune + PA Consulting) | Chief Business Officer (CBO) | Achilles Therapeutics (Group) | East of England (region) |
Carrick, Natalie (Automation Partnership 200209 Cell Biology Application Manager) | Product Manager (personnel) | Sartorius (Group) | East of England (region) |
Carroll, Jason (Azeria Therapeutics 201809 CSO + Founder + Univ Cambridge 201809 Prof at Cancer Research UK Institute) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Azeria Therapeutics Ltd. | East of England (region) |
Carter, Paul (Phoenix Marcom 201109 Managing Director) | Managing Director | Scott Partnership (Scott PR) (Group) | East of England (region) |
Cassidy, John W. (Cambridge Cancer Genomics 201812 CEO Co-Founder) | Chief Executive Officer (CEO) | Dante Genomics (Group) | East of England (region) |
Casson, Duncan (Kymab 201303– Chief Developm Officer before PanGenetics COO + CAT + Genzyme) | Research & Development Manager | Sanofi (Group) [since May 2011] | East of England (region) |
Castellano, Thomas (Abzena 202306– CFO before Catalent + Lehman Brothers + Cendant Corp) | Chief Financial Officer (CFO) | Abzena (Group) | East of England (region) |
Champaneri, Jay (Cambridge Bioscience 201111 Business Manager) | Sales Manager / Marketing Manager | Cambridge Bioscience Ltd. | East of England (region) |
Chandler-Smith, Karen (Inivata 201903 Media Realtions before BIA 201406 Director of BusDev + Membership Services) | Public Relations Manager / Investor Relations Manager | NeoGenomics (Group) | East of England (region) |
Chapple, Daniel (Quanticate 201111 VP Global Business Development + Marketing before Cognizant + ICON + MDS) | Business Development Manager / Strategy Manager | Quanticate (Group) | East of England (region) |
Chen, Michael C. (Nuclera 202202 CEO + Co-Founder) | Chief Executive Officer (CEO) | Nuclera (Group) | East of England (region) |
Cheng, Pam P. (AstraZeneca 201506– EVP Operations + IT before Merck/MSD China + Union Carbide + GAF Chemicals) | Chief Operating Officer (COO) | AstraZeneca (Group) | East of England (region) |
Chin, Jason W. K. (United Kingdom (govt) 202308 MRC + Co-Founder + CSO of Constructive Biology) | n. a. | United Kingdom (GB) (govt) | East of England (region) |
Chiswell, David (Kymab 201604–201904 CEO before interim CEO since early 2015 before Nabriva + Albireo + CAT + Amersham) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | East of England (region) |
Choo, Yen (Plasticell 200701 CEO) | Chief Executive Officer (CEO) | Plasticell Ltd. | East of England (region) |
Christou, Victor (Cambridge Innovation Capital 201608 CEO) | Chief Executive Officer (CEO) | Cambridge Innovation Capital (Group) | East of England (region) |
Clark, Neil (CeNeS 200702 CEO) | Chief Executive Officer (CEO) | Humanwell Healthcare (Group) | East of England (region) |
Clarke, Graham (ImmunoBiology 201210 CEO) | Chief Executive Officer (CEO) | ImmunoBiology Ltd. (ImmBio) | East of England (region) |
Clarke, Lindsey (MicrofluidX 202303– VP Commercial before Ori Biotech + Bio-Techne + Miltenyi Biotec) | Business Development Manager / Strategy Manager | MicrofluidX Ltd. | East of England (region) |
Claxton, Chris (Owlstone Medical 201807– Head Investor Relations before Horizon Discovery) | Public Relations Manager / Investor Relations Manager | Owlstone (Group) | East of England (region) |
Clifford, Harry (Cambridge Cancer Genomics 201812 CTO & Co-Founder) | Chief Technology/Technical Officer (CTO) | Dante Genomics (Group) | East of England (region) |
Clube, Jasper (Diversys 200205 Director Intellectual Property) | IP Manager | GSK (Group) | East of England (region) |
Cohen, Samuel (Wren Therapeutics 201901– CEO + Co-Founder) | Chief Executive Officer (CEO) | Wren Therapeutics Ltd. | East of England (region) |
Colaco, Camilo (ImmunoBiology 201210 CSO + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ImmunoBiology Ltd. (ImmBio) | East of England (region) |
Cole, Sarah (Transine Therapeutics 202106 VP RnD + Operations) | Research & Development Manager | Transine Therapeutics Ltd. | East of England (region) |
Collier, Adam (Spirea 202007 Head of Buiness Operations before Medimmune + Ablynx + Isogenica + Horizon Discovery) | Business Development Manager / Strategy Manager | Spirea Ltd. | East of England (region) |
Collins, Peter (Inivata 202009– CBO before Yourgene Health + GSK + Qiagen + DxS) | Business Development Manager / Strategy Manager | NeoGenomics (Group) | East of England (region) |
Conduit, Gareth (Intellegens 201801 Founder) | Company Founder | Intellegens Ltd. | East of England (region) |
Cons, Ben (DefiniGen 202201 Board Chair) | Board member, non-executive | DefiniGen Ltd. | East of England (region) |
Cook, David (AstraZeneca 200904 Global Safety Assessment 200607 Associate Director Pathways Capability) | Clinical Research Manager | AstraZeneca (Group) | East of England (region) |
Cook, Emily (Lexington Communications 20202 Director + Head of Lexington Health practice) | Public Relations Manager / Investor Relations Manager | Lexington Communications | East of England (region) |
Cook, Grahame (Horizon Discovery 2015– Non-executive Board Director) | Board member, non-executive | PerkinElmer (Group) | East of England (region) |
Cornell, Clive (Selcia 201801 COO) | Chief Operating Officer (COO) | Eurofins (Group) | East of England (region) |
Correa de Sampaio, Pedro (Neobe Therapeutics 202210 CEO + Co-Founder) | Chief Executive Officer (CEO) | Neobe Therapeutics Ltd. | East of England (region) |
Coutts, Robert (Achilles Therapeutics 202012– CFO joined as finance director since founding 2017 before Syncona) | Chief Financial Officer (CFO) | Achilles Therapeutics (Group) | East of England (region) |
Cowan, Paul (Quotient Bioscience 200904 CEO) | Chief Executive Officer (CEO) | Quotient Bioscience (Group) | East of England (region) |
Crabtree, Amy (Blue Scientific 201602 Graphics + Marcoms) | Public Relations Manager / Investor Relations Manager | Blue Scientific Ltd. | East of England (region) |
Craig, Frank F. (Sphere Fluidics 201711 CEO) | Chief Executive Officer (CEO) | Sphere Fluidics (Group) | East of England (region) |
Craven, James (CN Bio 202009 CCO before Titian Software 201512– Head Global Marketing + TTP Labtech + HighRes Bio) | Chief Commercial Officer (CCO) | CN Innovations (Group) | East of England (region) |
Crawford, Fran (Altacor 201111 CEO) | Chief Executive Officer (CEO) | Altacor Ltd. | East of England (region) |
Crockett, Nigel (Bicycle Therapeutics 201910– CBO + Microbiotica 201710 Head BusDev before Tukan Partners + Astex) | Chief Business Officer (CBO) | Bicycle Therapeutics (Group) | East of England (region) |
Cuddon, Lorna (Zyme Communications 201007– Managing Director + Founder before College Hill Life Sciences) | Managing Director | Zyme Communications Ltd. | East of England (region) |
Damour, Bertrand (Pheon Therapeutics 202209– CEO before NBE Therapeutics + Synthena + OncoEthix + Egalet + GeneProt) | Chief Executive Officer (CEO) | Pheon Therapeutics (Group) | East of England (region) |
Dancer, Jane E. (F-Star 201205– COO before Cellzome 200801– VP BusDev before CAT) | Chief Operating Officer (COO) | Sino Biopharm (Group) | East of England (region) |
Davies, Mike (F-Star 201606 VP Protein Science) | n. a. | Sino Biopharm (Group) | East of England (region) |
Davis, Mark (Mologic Ltd 201805 CEO + Co-Founder) | Chief Executive Officer (CEO) | Mologic (Group) | East of England (region) |
Day, Richard (Essex Scientific 201103 Service Manager) | n. a. | Essex Scientific Laboratory Supplies Ltd. (ESSLAB) | East of England (region) |
Dearlove, Andrew (Geneservice 200506 BusDev Manager) | Business Development Manager / Strategy Manager | Source BioScience (Group) | East of England (region) |
Deloukas, Panos (Sanger Institute 200509) | n. a. | Wellcome Trust, The | East of England (region) |
Denison, Robert (Rob) (Congenica 202206– CEO joined 201909 as Chief Information Officer) | Chief Executive Officer (CEO) | Congenica (Group) | East of England (region) |
Devlin, Clare (Optibrium 201901– Financial Director before Scintacor + Addviso + Genestack) | Chief Financial Officer (CFO) | Optibrium (Group) | East of England (region) |
Dhaliwal, Kam (Horizon Discovery 201108 Director Business Development before Evotec + Acumen Bioscience) | Business Development Manager / Strategy Manager | PerkinElmer (Group) | East of England (region) |
Disley, Darrin M. (Mogrify 201902– CEO of Cell Mogrify Ltd before 11 years at Horizon Discovery) | Chief Executive Officer (CEO) | Mogrify (Group) | East of England (region) |
Dobbs, Felix (Broken String Biosciences 202309 CEO) | Chief Executive Officer (CEO) | Broken String Biosciences Ltd. | East of England (region) |
Dobrée, Anne (Univ Cambridge 201812 Head of Seed Funds at Cambridge Enterprise) | Investment Manager | University of Cambridge | East of England (region) |
Dobson, Chris (Univ Cambridge 201901 Professor) | Professor | University of Cambridge | East of England (region) |
Dougherty, Martin (Wellcome Trust 201505 COO of Sanger Institute) | Chief Operating Officer (COO) | Wellcome Trust, The | East of England (region) |
Douglas, Graeham (Arete Medical Technologies 201912 CEO + Founder) | Chief Executive Officer (CEO) | Arete Medical Technologies Ltd. | East of England (region) |
Droguet, Benjamin (Sparxell 202209– CEO + Co-Founder) | Chief Executive Officer (CEO) | Sparxell UK Ltd. | East of England (region) |
Dunoyer, Marc (AstraZeneca 201311– CFO joined 201303 as EVP Global Portfolio + Product Strategy before GSK) | Chief Financial Officer (CFO) | AstraZeneca (Group) | East of England (region) |
Edgson, Ray (Cambridge Consultants 201607 Ventures Director) | Investment Manager | Cambridge Consultants Ltd. | East of England (region) |
Efthymiopoulos, Konstantinos (Funxional Therapeutics 201005 CEO) | Chief Executive Officer (CEO) | Funxional Therapeutics Ltd. (FXT) | East of England (region) |
Egerton, Mark (Quotient Bioresearch 201010) | n. a. | Quotient Bioresearch (Group) | East of England (region) |
Ekblom, Anders (AstraZeneca 199301– Executive VP Development before Karolinska Institutet) | Research & Development Manager | AstraZeneca (Group) | East of England (region) |
Espinet, Antoine Jean (MicrofluidX 201810– CEO + Founder) | Chief Executive Officer (CEO) | MicrofluidX Ltd. | East of England (region) |
Evans, Hilary (Alzheimer’s Research UK 202212 Chief Executive) | Chief Executive Officer (CEO) | Alzheimer’s Reserach UK | East of England (region) |
Fairhead, Heather (Phico Therapeutics 201808 CEO) | Chief Executive Officer (CEO) | Phico Therapeutics Ltd. | East of England (region) |
Famm, Kris (GSK 201608– President Galvani Bioelectronics before VP Bioelectronics RnD + Head Protein Degration Tech) | President/Director/Head Business Group/Unit/Division | GSK (Group) | East of England (region) |
Farrant, Elizabeth (Cyclofluidic 2011– CBO before Pfizer UK Sandwich) | Chief Business Officer (CBO) | Pfizer (Group) | East of England (region) |
Fear, Harriet (Deyton Bell 201901– Director before Consultant + One Nucleus 2009–201707 CEO + British Foreign Service) | President/Director/Head Business Group/Unit/Division | Deyton Bell Ltd. | East of England (region) |
Fellner, Peter (Acambis 200703 President) | Board member, non-executive | Sanofi (Group) [since May 2011] | East of England (region) |
Finbow, Anthony (Eagle Genomics 201501– CEO before Executive Chairman) | Chief Executive Officer (CEO) | Eagle Genomics Ltd. | East of England (region) |
Flanders, David (Eagle Genomics 201201 CEO before Stem Cells Inc UK + Lion Bioscience) | Chief Executive Officer (CEO) | Eagle Genomics Ltd. | East of England (region) |
Fliri, Hans (Selcia Ltd 200601 Managing Director) | Managing Director | Eurofins (Group) | East of England (region) |
Forster, Eliot (F-Star 201810– CEO before Immunocore + Creabilis + Solace Pharmaceuticals + Pfizer + GSK) | Chief Executive Officer (CEO) | Sino Biopharm (Group) | East of England (region) |
Forsyth, Sally Ann (Stevenage Bioscience Catalyst 201803– CEO before CEO of Norwich Research Park since 2013) | Chief Executive Officer (CEO) | Stevenage Bioscience Catalyst (SBC) | East of England (region) |
Foster, Nick (Metrion Biosciences 202107– CCO + Head Global BusDev before WuXi AppTec + Optibrium + BioFocus Ltd) | Chief Commercial Officer (CCO) | Metrion Biosciences Ltd. | East of England (region) |
Frail, Don (AstraZeneca 201310 VP + Head of Emerging Innovations, Science Partnerships + Alliances) | Business Development Manager / Strategy Manager | AstraZeneca (Group) | East of England (region) |
Fraundorfer, Ralph (Tropic Biosciences 202006 CFO) | Chief Financial Officer (CFO) | Tropic Biosciences UK Ltd. | East of England (region) |
Frayling, Cameron (Lightcast Discovery 201902– CEO + Co-Founder before Base4 201307 CEO + founder) | Chief Executive Officer (CEO) | Lightcast Discovery Ltd. | East of England (region) |
Fredrickson, David (AstraZeneca 201711 EVP Head of Oncology Business Unit) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | East of England (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top